Please ensure Javascript is enabled for purposes of website accessibility
UCSF Aerosol Straitjackets COVID-19, 100% Effective in Lab
TLBBHMAP3-U010ALB5ANM-348f959abae2-512-300x300-1
By Jim Jakobs, Digital Producer
Published 4 years ago on
August 14, 2020

Share

UCSF researchers say that they have come up with an aerosol spray that if used once a day could provide reliable protection against COVID-19 until a vaccine is available.

“It was so effective that it exceeded our ability to measure its potency.” — Peter Walter, UCSF professor of biochemistry and biophysics

The powerful protectant — dubbed AeroNabs — could be inexpensively manufactured, thus widening its appeal. The research team is in discussions with potential commercial partners who are interested in making and distributing AeroNabs.

The hope is to commence human trials soon and have it on store shelves by year’s end as an over-the-counter medication to prevent and treat COVID-19.

In a laboratory setting, the results were “off the charts,” said UCSF’s Peter Walter, co-inventory of AeroNabs. “It was so effective that it exceeded our ability to measure its potency.”

The nasal spray acts like a mousetrap and puts a sheath over the spike proteins of COVID-19 thus rendering it helpless to attach to human cells.

That’s important because COVID-19 relies on its so-called spike proteins to infect cells. These spikes are the key that allows the virus to enter human cells.

The Lock and Key Explanation

Though engineered entirely in the lab, AeroNabs were inspired by nanobodies — antibody-like immune proteins that naturally occur in llamas, camels, and related animals.

These nanobodies function a bit like a sheath that covers the RBD “key” and prevents it from being inserted into an ACE2 “lock.”

“By binding to the spike protein, the Aeronab locks it into an ineffective state where it can no longer interact with the cell receptor,” said Walter, who spoke to GV Wire℠ via Zoom.

Don’t get hung up on the medical terminology, just know the key must go into the lock for COVID-19 to take hold of a human cell and force it to produce more COVID-19.

COVID-19 relies on its so-called spike proteins to infect cells. (UCSF)
Nanobodies function like a sheath, covering the RBD “key” and preventing it from being inserted into an ACE2 “lock.”( UCSF)

Using the three most promising nanobodies against live COVID-19, researchers found the nanobodies to be extraordinarily potent. They prevented infection even at extremely low doses.

“If AeroNabs prove as effective as we anticipate, they may help reshape the course of the pandemic worldwide.” — UCSF’s Dr. Aashish Manglik, co-inventor of AeroNabs

The most potent of these nanobodies, however, not only acts as a sheath over RBDs but also like a molecular mousetrap. This provides an additional layer of protection against the spike–ACE2 interactions that lead to infection.

“Far more effective than wearable forms of personal protective equipment, we think of AeroNabs as a molecular form of PPE that could serve as an important stopgap until vaccines provide a more permanent solution to COVID-19,” said Walter.

Says co-inventor Dr. Aashish Manglik: “We’re not alone in thinking that AeroNabs are a remarkable technology. …  If AeroNabs prove as effective as we anticipate, they may help reshape the course of the pandemic worldwide.”

Final Experiments

In a final set of experiments, the researchers put the three-part nanobodies through a series of stress tests, subjecting them to high temperatures, turning them into a shelf-stable powder, and making an aerosol.

Each of these processes is highly damaging to most proteins, but the scientists found that “thanks to the inherent stability of nanobodies, there was no loss of antiviral potency in the aerosolized form, suggesting that AeroNabs are a potent COVID-19 antiviral that could be practical to administer via a shelf-stable inhaler or nasal spray.”

[covid-19-tracker]

Approval Process

If AeroNabs succeed in human trials, Walter said that approval for going to market could come quickly.

“Here the approval should be easier because a vaccine interacts with the physiology of the human body, and the human body has to react to the vaccine to produce its own antibodies which then gives a lasting effect,” said Walter. “AeroNabs only interact with the virus, they don’t pay any attention to the human body.”

DON'T MISS

Paul McCartney Becomes Britain’s First Billionaire Musician

DON'T MISS

California Cracked Down After a Crash Killed 13 Farmworkers. Why Are Workers Still Dying on the Road?

DON'T MISS

These Rare Chainsaws Are Worth Big Bucks to Collectors

DON'T MISS

Jewish Lobby Presses California Lawmakers to Combat Antisemitism

DON'T MISS

Opinion: How Urban Renewal Ruined Everything

DON'T MISS

California Wine Squeezed Dry: Insiders Say It’s Time to Pull up Acreage

DON'T MISS

Alabama Mercedes Employees Overwhelmingly Vote Against Joining Union, Slowing UAW Effort in South

DON'T MISS

Stock Market Today: Dow Finishes Above 40,000 to Cap Wall Street’s Latest Winning Week

DON'T MISS

Where Do State Lawmakers Stand on War in Gaza, Campus Protests?

DON'T MISS

High-Speed Rail Now Working to Extend Valley Line to 171 Miles

UP NEXT

Jewish Lobby Presses California Lawmakers to Combat Antisemitism

UP NEXT

Where Do State Lawmakers Stand on War in Gaza, Campus Protests?

UP NEXT

$20 Billion: The Delta Tunnel’s New Price Tag

UP NEXT

Billionaires Urged NYC Mayor to Use Police on Columbia Protesters, Chats Reveal

UP NEXT

Psychedelic Therapy and Workers’ Rights Bills Fail to Advance in California’s Tough Budget Year

UP NEXT

Man Sentenced to 30 Years for Hammer Attack on Nancy Pelosi’s Husband

UP NEXT

Chip Foose: Maestro of Metal, Magic, Mind-Blowing Machines

UP NEXT

The Latest Hot Spot for Illegal Border Crossings Is San Diego. But Routes Change Quickly

UP NEXT

Lainey Wilson Triumphs at 2024 Academy of Country Music Awards

UP NEXT

California Professor to Stand Trial for Death of Pro-Israel Protester

Jewish Lobby Presses California Lawmakers to Combat Antisemitism

2 days ago

Opinion: How Urban Renewal Ruined Everything

2 days ago

California Wine Squeezed Dry: Insiders Say It’s Time to Pull up Acreage

2 days ago

Alabama Mercedes Employees Overwhelmingly Vote Against Joining Union, Slowing UAW Effort in South

2 days ago

Stock Market Today: Dow Finishes Above 40,000 to Cap Wall Street’s Latest Winning Week

2 days ago

Where Do State Lawmakers Stand on War in Gaza, Campus Protests?

2 days ago

High-Speed Rail Now Working to Extend Valley Line to 171 Miles

2 days ago

Beautify Fresno Combines Dog Adoption, Litter Removal in Unique Saturday Event

2 days ago

Bulldogs’ Gilmore Named MW Softball Pitcher of the Year

2 days ago

The Latest | Dozens of Israeli Protesters Attack a Truck in an Apparent Effort to Block Gaza Aid

2 days ago

Paul McCartney Becomes Britain’s First Billionaire Musician

LONDON — Paul McCartney is a billionaire Beatle. According to figures released Friday, the former member of the Fab Four is the first Britis...

24 hours ago

24 hours ago

Paul McCartney Becomes Britain’s First Billionaire Musician

1 day ago

California Cracked Down After a Crash Killed 13 Farmworkers. Why Are Workers Still Dying on the Road?

1 day ago

These Rare Chainsaws Are Worth Big Bucks to Collectors

2 days ago

Jewish Lobby Presses California Lawmakers to Combat Antisemitism

2 days ago

Opinion: How Urban Renewal Ruined Everything

2 days ago

California Wine Squeezed Dry: Insiders Say It’s Time to Pull up Acreage

2 days ago

Alabama Mercedes Employees Overwhelmingly Vote Against Joining Union, Slowing UAW Effort in South

2 days ago

Stock Market Today: Dow Finishes Above 40,000 to Cap Wall Street’s Latest Winning Week

MENU

CONNECT WITH US

Search

Send this to a friend